InvestorBrandNetwork (IBN) Content Platform

The MeridianBet Group (“Meridian”), one of the world’s leading sports betting and gaming groups, operating in multiple markets across Europe, Africa and Latin America, is being acquired by Golden Matrix Group (NASDAQ: GMGI), with completion expected by late March 2024. Meridian today announced that its dedicated subsidiary specializing in online casino game development, Expanse Studios, will be featuring its three latest game releases at ICE London 2024 (Feb. 6-8). According to Meridian CEO Zoran Milosevic, Expanse Studios’ three new exciting games – Leprechaun Wish, Shaolin Crew and Pinata Loca – “represent the cutting edge of casino entertainment and bring a new dimension to online gaming, offering an array of features and benefits that will be extremely popular with casino operators and their players. We are excited to be highlighting these games at one of the largest gaming conferences in the world and expect them to be very well-received.”

To view the full press release, visit https://ibn.fm/kZKud

About Golden Matrix Group Inc.

Golden Matrix Group, based in Las Vegas, Nevada, is an established business-to-business (“B2B”) and business-to-consumer (“B2C”) gaming technology company operating across multiple international markets. The B2B division of Golden Matrix develops and licenses proprietary gaming platforms for its extensive list of clients and RKings, its B2C division, operates a high-volume eCommerce site enabling end users to enter paid-for competitions on its proprietary platform in authorized markets. The company also owns and operates MEXPLAY, a regulated online casino in Mexico. The company’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with current U.S. law.

NOTE TO INVESTORS: The latest news and updates relating to GMGI are available in the company’s newsroom at https://ibn.fm/GMGI

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal-pest populations, has entered a distribution agreement with a leading Singapore-based pest-control product manufacturer and distributor: Agro Technic PTE Ltd. According to the announcement, the agreement includes a significant initial stocking order as well as annual minimums. The product range that SenesTech provides is a “perfect fit” for the Agro Technic business model, long-term strategy and market positioning, according to Agro Technic. The company is committed to offering market solutions that are both environmentally friendly but effective. “Agro Technic is a leading manufacturer and supplier for equipment and chemicals in Singapore, with a strong presence in public-health vector control, professional pest control and plant protection,” said SenesTech president and CEO Joel Fruendt in the press release. “With their focus on putting forth customized solutions to meet customers’ needs in Singapore and throughout the region, they are an excellent partner for SenesTech as we address that market.”

To view the full press release, visit https://ibn.fm/zRNRk

About SenesTech Inc.

SenesTech is committed to improving the health of the world by humanely managing animal-pest populations through fertility control. SenesTech is an expert in fertility control to manage animal pest populations. The company invented ContraPest, the only U.S. EPA-registered contraceptive for male and female rats, and Evolve, an EPA-designated minimum-risk contraceptive currently offered for rats. ContraPest and Evolve fit seamlessly into all integrated pest-management programs, significantly improving the overall goal of effective pest management. The company strives for clean cities, efficient businesses and happy households by providing a product designed to be humane, effective and sustainable. For more information about the company, please visit www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IGEN Networks (OTC: IGEN) CEO Neil G. Chan is providing a status report on the company’s key initiatives; IGEN is a leading innovator of solutions for the consumer automotive, fleet management and supply-chain industries. In the update, Chan discusses new opportunities for the company, noting that IGEN has focused on the following: opportunities within the commercial side of its business; new technologies, which included offering an integrated all-in-one solution that address the SME (“SME”) business supply-chain requirements at lower costs and on a subscription basis; and new marketing channels, which involved IGEN signing a comarketing agreement with a Fortune 100 wireless carrier. “In preparation for completing these key initiatives, the company has extinguished all outstanding debt for an exchange of Preferred Series A shares with Jefferson Street Capital LLC (‘JSC’), along with JSC’s continued support of IGEN through a previously announced $5 million equity line,” stated the company in the press release. “[IGEN] has also replaced all Amazon Web Services (‘AWS’)-based services with in-house infrastructure, single sourced hardware from South Korea rather than China to mitigate supply-chain risks and secured several whole-sale airtime service packages with two major U.S. wireless carriers, thereby reducing operating costs severalfold. Combined with our Fortune 100 wireless carrier, IGEN will be positioned to become the first mover on evolving opportunities for the SME supply-chain industry as we welcome 2024 and beyond.”

To view the full press release, visit https://ibn.fm/6nsuk

About IGEN Networks Corporation

IGEN Networks creates software services for the commercial asset management industries enabling its customers to better manage their assets and improve productivity. For more information about the company, please visit www.IGENNetworks.net.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has enrolled and dosed the first patient in the phase 2a expansion portion of its Acclaim-1 clinical study of Reqorsa(R) therapy (quaratusugene ozeplasmid). The study combines Genprex’s proprietary lead product candidate with AstraZeneca’s Tagrisso(R) to treat patients with late-stage non-small cell lung cancer (“NSCLC”). An open-label, multicenter phase 1/2 clinical trial, the Accliam-1 trial has completed its phase 1 component and is moving on to phase 2. The company anticipates enrolling an estimated 66 patients in phase 2a, with one-half of the study participants receiving Tagrisso treatment alone and the other half receiving Tagrisso treatment and chemotherapy; the study will determine toxicity profiles of patients with different eligibility criteria, as well as efficacy and other endpoints.

There will be an interim analysis following the treatment of 19 patients in each cohort. The company plans to enroll an estimated 74 patients in the phase 2b randomized portion of the study; those patients will be randomized to receive either REQORSA and Tagrisso combination therapy or platinum-based chemotherapy with the primary endpoint of the phase 2b study being progression-free survival. Genprex plans to complete enrollment of phase 2a expansion study by the end of 2024.“Advancing Acclaim-1 marks an important milestone for Genprex,” said Genprex president, chairman and CEO Rodney Varner in the press release. “We are proud of the progress we have made thus far and are encouraged by REQORSA’s potential to improve outcomes for patients battling NSCLC. We look forward to an interim analysis from the phase 2a study in 2025 and expect those results will further validate our novel gene therapy approach to treating lung cancer patients.”

To view the full press release, visit https://ibn.fm/nJNjZ

About Genprex Inc. 

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes that currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, nonviral ONCOPREX(R) Nanoparticle Delivery System, which encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that are deficient in the tumor. The company’s lead product candidate, REQORSA (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for non-small cell lung cancer (“NSCLC”) and small cell lung cancer (“SCLC”). Each of Genprex’s three lung cancer clinical programs has received a fast-track designation from the Food and Drug Administration for the treatment of that patient population, and Genprex’s SCLC program has received an FDA Orphan Drug Designation. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an adeno-associated virus (“AAV”) vector to deliver Pdx1 (“Pdx1”) and MafA (“MafA”) genes to the pancreas. In models of type 1 diabetes, GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which can produce insulin but may be distinct enough from beta cells to evade the body’s immune system. In a similar approach, GPX-003 for type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. For more information, please visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision solutions, today announced the successful completion of two proof of concept (“POC”) projects with a leading Japanese vehicle manufacturer. Foresight reported the initiation of these projects on Aug. 14, 2023. According to the update, the vehicle manufacturer, currently employing stereo cameras in its advanced driver assistance systems (“ADAS”), evaluated the accuracy of Foresight’s unique automatic calibration capabilities to enhance 3D depth perception. Following satisfactory results, the parties are exploring co-development initiatives to further evaluate the solution’s capabilities.

To view the full press release, visit https://ibn.fm/5KR1X

About Foresight Autonomous Holdings Ltd.

Foresight is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, is hosting a teleconference today. According to the announcement, during the call company officials will discuss the recent acquisition of Uncle Bud’s (“UB”) and other ongoing opportunities the company is pursuing. The company noted that Uncle Bud’s, a natural health and wellness innovator, is planning to launch its UltraShear-processed Premium Collection of state-of-the-art nanoemulsified products by March 1, 2024. The new line of products combines the best of science and nature to establish a new benchmark for quality, purity and effectiveness. The products, led by CBD Body Revive Spray with 1200 mg of nano CBD, will be processed using PBIO’s multipatented UltraShear Technology(TM), or UltraShear(TM) or UST(TM).

According to the announcement, the teleconference will begin at 4:30 p.m. ET. Those interested can call 888-267-2918 and then use code 973092. “What an exciting time for all stakeholders in PBIO,” said PBIO director of sales and marketing John Hollister in the press release. “With revenues of $5 million anticipated from Uncle Bud’s in 2024, combined with revenues of $5 million anticipated from historical PBIO products/services, we believe total 2024 revenues could be 5X or more of our historical annual revenue.”

To view the full press release, visit https://ibn.fm/u1bxe

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. PBIO’s patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counterbioterrorism applications. The company’s BaroFold(TM) technology platform allows PBIO to enter the biopharma contract services and GMP manufacturing equipment sector. PBIO has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

• Arizona-based rat population control innovator SenesTech is expanding the market for its unique non-lethal, fertility-reduction products by partnering with a sustainable solutions irrigation company to roll out Evolve(TM) soft bait to open field agriculture
• Rodent population increases have been widely reported in the wake of the COVID pandemic, and SenesTech’s solution is easier to distribute than many poisons and doesn’t carry the high risk of unintentionally harming non-target species
• The company has introduced its products in the United States, Hong Kong, the Maldives, and the United Arab Emirates
• SenesTech’s irrigation solutions partner will initially introduce Evolve(TM) to a California dairy and almond operation, with the goal of expanding distribution to its other customers worldwide

Rodent pest control enterprise SenesTech (NASDAQ: SNES) is expanding its unique rat birth control product line through a team-up with a global leader in irrigation solutions to place SenesTech’s soft bait solution into open field agriculture.

SenesTech is rapidly growing, making a name for itself by targeting the spread of rodent populations through the use of a non-lethal method of intervention in conjunction with or instead of the poisons common to the pest control industry. Its original liquid formulation ContraPest(R) showed success in…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Mountain Top Properties (OTC: MTPP), a diversified real estate holding company, is seeking to raise up to $10 million in gross proceeds from a Regulation A offering. The company intends to deploy the proceeds to support its real estate development plans within the exclusive Hamptons real estate market. “In addition, the company is planning to expand on its technologically driven property management business centered on the larger Northeastern U.S. region. Through its Mountain Top Capital Fund I, Mountain Top Realty has sought to raise $75 million to build, acquire, renovate, and remarket homes in the Hamptons; thus far, the fund has already received debt capital commitments amounting to 70% of anticipated real estate acquisition costs as well as a further 100% of the planned construction costs, a figure which the company will seek to complement its upcoming equity raising exercise. Mountain Top Properties will subsequently look to soon deploy up to $10 million to leverage strategic waterfront or water view opportunities within the exclusive enclave offering a significant return on capital,” a recent article explains. “In addition to Mountain Top Properties’ real estate development efforts in Long Island’s Hamptons region, which is slated to commence in the spring, the company expects to begin generating revenues from its property management activities in the first quarter of 2024.”

To view the full article, visit https://ibn.fm/3FYgZ

About Mountain Top Properties Inc.

Mountain Top Properties is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment. Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York. For more information, visit the company’s website at www.Mountain-Top-Properties.com.

NOTE TO INVESTORS: The latest news and updates relating to MTPP are available in the company’s newsroom at https://ibn.fm/MTPP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

HUB Cyber Security (NASDAQ: HUBC) (“HUB Security”), a developer of confidential computing cybersecurity solutions and services, reported sealing an additional contract with a subsidiary of a giant credit service provider with a market cap of hundreds of billions of dollars. The new contract brings the engagement to a six-figure number in deals over a few tranches and represents the subsidiary’s renewed trust in Hub Cyber Security. Under the agreement, the credit card services company will integrate HUB Security’s cybersecurity services, enhancing compliance and statutory, regulatory and contractual obligations pertaining to information security and privacy. The integration is expected to protect against emerging cyber security threats. “We are excited to enhance our partnership with one of the leading companies in the financial services sector. This agreement is a testament to our successful partnership and achievements and mirrors our joint dedication to pioneering solutions and security. Hub Security is keen to support the ongoing prosperity of our distinguished collaborator,” said Noah Hershcoviz, CEO of HUB Cyber Security.

To view the full press release, visit https://ibn.fm/yIGyS

About HUB Security Ltd.

HUB Cyber Security (“HUB Security”) was established in 2017 by veterans of the elite intelligence units of the Israeli Defense Forces. The company specializes in unique cybersecurity solutions protecting sensitive commercial and government information. The company debuted an advanced encrypted computing solution to prevent hostile intrusions at the hardware level while introducing a novel set of data theft prevention solutions. HUB Security operates in over 30 countries and provides innovative cybersecurity computing appliances as well as a wide range of cybersecurity services worldwide.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DEEP GREEN Waste & Recycling (OTCQB: DGWR), a waste, recycling and remediation services company for commercial customers, recently announced its successful uplisting from the OTC Pink Sheets to the OTCQB(R) Venture Market (the “OTCQB”). The company commenced trading under the symbol DGWR on the OTCQB on Jan. 22, 2024. “Being listed on the OTCQB is an important milestone for DEEP GREEN and will offer the company broader acceptance within the investment banking community,” said Bill Edmonds, chairman and CEO of DEEP GREEN Waste & Recycling. “Uplisting to the OTCQB Exchange will benefit a broader range of institutional and retail shareholders and help the company continue to raise the capital needed to achieve its acquisition goals.”

To view the full press release, visit https://ibn.fm/flZ6E

About DEEP GREEN Waste & Recycling, Inc.

DEEP GREEN Waste & Recycling provides sustainable waste, recycling and remediation services and helps commercial customers realize cost-savings using streamlined processes that help manage, reduce and recycle waste streams. DEEP GREEN Waste & Recycling trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find real-time quotes and market information for the company on www.otcmarkets.com. For more information, visit: https://DeepGreenWaste.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Safety Shot (NASDAQ: SHOT), a wellness and functional beverage company, today announced that Safety Shot is the official recovery drink for events around football’s biggest game throughout the weekend of Feb. 11, 2024, in Las Vegas. According to the announcement, the Safety Shot wellness beverage will be featured at events, including Shaq’s Fun House, Sports Illustrated The Party, Gronk Beach, and Guy Fieri’s Flavortown Tailgate. Each event will have a dedicated Safety Short bar, with the main stages at all four events featuring Safety Shot alongside the party’s host on stage for a “Recovery Round” moment when free shots of Safety Shot will be passed out to all attendees. The patented Safety Shot is the world’s first alcohol detoxifier that reduces blood alcohol content in as little as 30 minutes through several factors that help process alcohol more efficiently while also helping the body maintain hydration and improve the overall feeling of wellbeing through nootropics and vitamins. “This is our biggest brand launch event to date and it’s only fitting that it be in conjunction with the biggest names around football’s biggest game. Safety Shot will share the stage with football greats like Rob Gronkowski at Gronk Beach,” said Josh Wagner, Safety Shot’s chief revenue officer.

To view the full press release, visit https://ibn.fm/oxWad

About Safety Shot Inc.

Safety Shot, a wellness and functional beverage company, is set to launch Safety Shot, the first patented wellness beverage on Earth that helps people feel better faster by reducing blood alcohol content, boosting clarity and overall mood. Safety Shot has been available for retail purchase since the first week of December 2023 at www.DrinkSafetyShot.com and www.Amazon.com. The company plans to launch business-to-business sales of Safety Shot to distributors, retailers, restaurants, and bars in the first quarter of 2024. Safety Shot plans to spin off legacy assets from its Jupiter Wellness business to unlock value for shareholders.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage pharmaceutical company focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for more patients suffering from cancer, has closed on its previously announced public offering. The offering, which closed on Jan. 30, 2024, was comprised of 1,555,555 shares of common stock (or prefunded warrants in lieu thereof) along with common warrants to purchase up to 1,555,555 shares of its common stock. The combined public offering price per share of common stock (or prefunded warrants in lieu thereof) and accompanying common warrant was $4.50. H.C. Wainwright & Co. LLC was the exclusive placement agent for the offering. “The common warrants have an exercise price of $4.50 per share, are immediately exercisable upon issuance and have a term of five years after their original issuance date,” stated the company in the press release. “The gross proceeds from the offering, before deducting placement agent fees and other offering expenses payable by the company, were $7 million (excluding any proceeds that may be received upon the exercise of the common warrants).”

To view the full press release, visit https://ibn.fm/r5XVe

About Processa Pharmaceuticals Inc.

Processa is a clinical-stage pharmaceutical company focused on developing next-generation chemotherapy (“NGC”) drugs to improve the safety and efficacy of cancer treatment. By combining Processa’s novel oncology pipeline with proven cancer-killing active molecules and Processa’s Regulatory Science Approach as well as experience in defining optimal dosage regimens for FDA approvals, the company not only will be providing better therapy options to cancer patients but will also increase the probability of FDA approval for its next-generation chemotherapy drugs following an efficient path to approval. The company’s approach to drug development, based on more than 30 years of drug-development experience, uses its proven Regulatory Science Approach, including the determination of the Optimal Dosage Regimen using the principles of the FDA’s Project Optimus Oncology Initiative. Processa’s NGC drugs are modifications of existing FDA-approved oncology drugs resulting in an alteration of the metabolism and/or distribution of these FDA-approved drugs while maintaining the existing mechanisms of killing the cancer cells. The advantages of Processa’s NGC drugs are expected to include fewer patients experiencing side effects that lead to dose discontinuation; more significant cancer response; and a greater number of patients — more than 250,000 patients treated each year for each drug —who will benefit from each NGC drug. Currently under development are three next-generation chemotherapy oncology treatments: Next Generation Capecitabine (PCS6422 and capecitabine to treat breast, metastatic colorectal, gastrointestinal, gastrointestinal, pancreatic and other cancers), Next Generation Gemcitabine (PCS3117 to treat pancreatic, lung, ovarian, breast and other cancers), and Next Generation Irinotecan (PCS11T to treat lung, colorectal, gastrointestinal, pancreatic and other cancers). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

iClick Interactive (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, has scheduled an extraordinary general meeting (“EGM”) of shareholders. According to the announcement, the meeting is slated to begin at 8 p.m. ET on March 7, 2024 (9 a.m. ET on March 8, 2024, Hong Kong time) in Hong Kong. The meeting has been called for stockholders to consider and vote on several items, including the proposal to authorize and approve the agreement and plan of merger by and among TSH Investment Holding Limited, its wholly owned subsidiary TSH Merger Sub Limited and iClick Interactive. The merger was announced in November 2023. iClick’s board of directors has unanimously authorized and approved the execution, delivery and performance of the merger agreement, the plan of merger and the consummation of the transactions, including the merger; the board has also unanimously resolved to recommend that the company’s shareholders and ADS holders vote for, among other things, the proposal to authorize and approve the execution, delivery and performance of the merger agreement, the plan of merger and the consummation of the transactions, including the merger.

To view the full press release, visit https://ibn.fm/zoPNo

About iClick Interactive Asia Group Limited

iClick is a leading enterprise and marketing cloud platform in China. The company’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information about the company, please visit www.iClick.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has received additional purchase orders from three existing clients. The orders are designed to expand current emergency communications programs. According to the announcement, the clients include a healthcare provider in Texas, a Colorado county and college. The POs are for a total of five new systems that will enhance access to existing emergency assistive services.

Knightscope’s modern blue light emergency phones and call boxes can be an essential component to “curing an overconfident dependence on cell phones,” the company noted. Not all people are carrying a cell phone everywhere they go, and there are often instances when a cell phone is inoperable due to a dead battery or no signal.

In addition, “it is possible that visitors to an area who are in need of assistance may not be familiar with the geography and landmarks, thus being unable to give dispatchers an exact or accurate location over a cell phone,” the company stated in the press release. “In extreme situations (e.g., major terrorist event, campus shooting, natural or manmade disasters such as hurricanes, tornadoes, earthquakes, floods, wildfire, hazardous materials spill, etc.), cell phone users may also experience overloaded networks from too many subscribers trying to access the system during emergent situations when emergency access is most needed.”

Knightscope’s proprietary devices are illuminated and strategically located to provide reliable access and protection when emergency services are needed. “They work day and night in all kinds of weather and even when communications are most congested,” the company concluded. “Blue light emergency phone systems also always report one’s precise location reliably, ensuring the expedited arrival of the appropriate type of help.”

To view the full press release, visit https://ibn.fm/EGOUA

About Knightscope, Inc.

Knightscope is an advanced public safety technology company that builds fully autonomous security robots and blue light emergency communications systems that help protect the places people live, work, study and visit. Knightscope’s long-term ambition is to make the United States of America the safest country in the world. For more information about the company, please visit www.Knightscope.com.

NOTE TO INVESTORS: The latest news and updates relating to KSCP are available in the company’s newsroom at https://ibn.fm/KSCP

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on novel formulations and drug delivery systems for traditional therapeutics and psychedelic treatments, today announced updates for its strategic 2024 focus for its clinical pipeline. According to the announcement, the company is advancing a diversified portfolio of four drugs targeting three health areas: mental health, chronic pain and neurology. “This year we are prioritizing clinical development of our post-traumatic stress disorder (‘PTSD’) therapeutic, SPC-15, in collaboration with Columbia University, and we plan to submit a Pre-Investigational New Drug Application (‘IND’) to the U.S. Food and Drug Administration (‘FDA’) by the end of the second fiscal quarter in 2024,” said Eric Weisblum, CEO of Silo. “Each of our novel therapeutics target underserved diseases with limited treatment options where we believe we can deliver quality medical care and make an impact.”

To view the full press release, visit https://ibn.fm/J580N

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions and central nervous system (“CNS”) diseases. Silo focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company’s lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. SP-26 is a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. Silo’s two preclinical programs are SPC-14, an intranasal compound for the treatment of Alzheimer’s disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (“MS”). Silo’s research and development programs are conducted through collaborations with Columbia University and the University of Maryland, Baltimore. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, is reporting additional positive results from preclinical studies investigating its newly announced therapeutic candidate, TGR-63, a potential treatment for Alzheimer’s disease. The company had already shared study results indicating that TGR-63 shows potential to alleviate plaque burden in Alzheimer’s cell lines and animal models. New results exhibit potential recovery of behavioral functions in an animal model of Alzheimer’s, which could indicate that TGR-63 could be used as a treatment for anxiety in human Alzheimer’s. The company observed that TGR-63 is a patent-pending molecule designed to disrupt the structure of the amyloid beta (“Aβ”) peptide, one of the key hallmarks of Alzheimer’s. “While we continue to progress our phase 2b trial of IGC-AD1 as a treatment for agitation in dementia due to Alzheimer’s, we are excited by the preclinical results of TGR-63, in particular the profound impact of the drug on plaques and on reducing anxiety in a transgenic Alzheimer’s mouse model,” said IGC Pharma CEO Ram Mukunda in the press release. “In line with IGC Pharma’s artificial intelligence and machine learning (‘AI/ML’) initiatives, we plan to leverage cutting-edge AI/ML tools for studying TGR-63’s toxicology and protein interactions. By harnessing the power of AI/ML, we expect to accelerate the journey of TGR-63 from preclinical to patient care. We continue progressing IGC-AD1 and TGR-63 enthusiastically and anticipate clinical milestone updates throughout 2024 from our strengthened AD pipeline.”

To view the full press release, visit https://ibn.fm/gBCYL

About IGC Pharma

IGC Pharma is pursuing innovative solutions to fight Alzheimer’s disease and related challenges. The company’s portfolio comprises five assets, all with a singular mission: to transform the landscape of Alzheimer’s treatment. IGC-AD1 and LMP target neuroinflammation, Aβ plaques and neurofibrillary tangles. IGC-AD1 is currently in a phase 2b clinical trial for agitation in dementia due to Alzheimer’s. TGR-63 targets Aβ plaque to disrupt the progression of Alzheimer’s disease. IGC-M3 targets the inhibition of Aβ plaque aggregation with the potential to create a profound impact on early-stage Alzheimer’s. IGC-1C targets tau and neurofibrillary tangles as a forward-thinking approach to Alzheimer’s therapy. In parallel, IGC Pharma is at the forefront of generative AI development, with projects including clinical trials, early detection of Alzheimer’s and drug interactions with cannabinoids. For more information, visit the company’s website at www.IGCInc.us.

NOTE TO INVESTORS: The latest news and updates relating to IGC are available in the company’s newsroom at https://ibn.fm/IGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Helix Advanced Communications & Infrastructure, Inc., operating as Allcan Distributors, today announced its entry into a partnership with Siyata Mobile (NASDAQ: SYTA) in the launch of ChatterPTT Canada, a nationwide broadband push-to-talk (“PTT”) service. The partnership will support Allcan Distributors’ introduction to Canada of its ChatterPTT, a comprehensive business communication service that allows instant connection between remote teams. Siyata Mobile will provide the hardware under the collaboration, and Allcan Distributors has placed its first stocking order of Siyata’s SD7 handset, a simple, functional and rugged Android-based PTT-only device. “We are pleased to align with Allcan Distributors as it launches its ChatterPTT service to all of Canada,” said Siyata’s CEO Marc Seelenfreund. “The team at Allcan understands the important role that simple, yet high-functioning hardware can play in supporting reliable communications. Our SD7 device is an ideal platform for the service as it has been proven to withstand rigorous environments while being simple to use. By leveraging our hardware, Allcan will be able to deliver a superior experience to its customers as it rolls out its new service.”

To view the full press release, visit https://ibn.fm/T0a1a

About Siyata Mobile Inc.

Siyata Mobile is a B2B global developer and vendor of next-generation push-to-talk (“PTT”) over cellular handsets and accessories. Its portfolio of rugged PTT handsets and accessories enables first responders and enterprise workers to instantly communicate over a nationwide cellular network of choice, to increase situational awareness and save lives. Police, fire and ambulance organizations as well as schools, utilities, security companies, hospitals, waste management companies, resorts and many other organizations use Siyata PTT handsets and accessories today. In support of its PTT handsets and accessories, Siyata also offers enterprise-grade in-vehicle solutions and cellular booster systems enabling customers to communicate effectively when they are in their vehicles, and even in areas where the cellular signal is weak. Siyata sells its portfolio through leading North American cellular carriers, and through international cellular carriers and distributors. Siyata’s common shares and its previously issued warrants trade on the Nasdaq under the symbols SYTA and SYTAW, respectively. Visit SiyataMobile.com and UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYTA are available in the company’s newsroom at https://ibn.fm/SYTA

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Finovate is Europe’s leading fintech conference that offers a phenomenal platform for companies and executives. They come together at Finovate to discover and discuss innovative ideas and develop impactful connections in various fintech verticals. Get important insights as experts delve deep into vital and trending topics of the fast developing fintech world.

At Finovate, you see the best operational strategies from financial influencers. Fintech firms and entrepreneurs must leverage this huge opportunity to develop networking ties with…

Read More>>

To know more, please visit https://ibn.fm/BTFPR

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Pressure BioSciences (OTCQB: PBIO), a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables, and specialty process development and testing services across global industries, including nutraceuticals, food and beverage, health and wellness, cosmetics, biotherapeutics and more, has scheduled a teleconference. The Feb. 5, 2024, event will focus on PBIO’s current, in-process move to new manufacturing space; the integration plan of the Uncle Bud’s team and product offerings into PBIO; and the significant growth expected from new UltraShear processed nanoemulsion products, which are forecast to grow the company’s total revenue to an estimated $10 million this year, an impressive five times increase. The presentation will also include a Q&A session. According to the announcement, the teleconference will begin at 4:30 p.m. ET. Those interested can call 888-267-2918 and then use code 973092.

To view the full press release, visit https://ibn.fm/NhX6B

About Pressure BioSciences Inc.

Pressure BioSciences is a global leader in providing innovative, broadly enabling, high-pressure-based solutions for a range of industries, including biotechnology, pharmaceutical, nutraceutical, cosmeceutical and agrochemical, as well as food and beverage manufacturing. The company’s products utilize both constant and alternating pressure. PBIO’s patented enabling technology platform, Pressure Cycling Technology (“PCT”), utilizes alternating cycles of pressure to control biomolecular interactions (such as cell lysis and biomolecule extraction) safely and reproducibly. PCT-based products are beginning to be widely used for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counterbioterrorism applications. The company has recently expanded its market opportunities with the acquisition of the BaroFold(TM) patented technology platform, allowing PBIO to enter the biopharma contract services and GMP manufacturing equipment sector. PBIO has also developed the scalable and high-efficiency pressure-based UltraShear Technology(TM) platform, which allows for the creation of stable nanoemulsions of otherwise immiscible fluids. It also allows for the preparation of higher quality, homogenized, extended shelf-life or room-temperature-stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. The company’s commitment to innovation and cutting-edge technology has established PBIO as a leader in the high-pressure industry, providing unique and effective solutions to its customers. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI), an innovative clean-technology company redefining power-conversion technologies, has reached a significant milestone for its ZVS-enabled power modules, positioning the company to take advantage of a potential new revenue stream. According to the announcement, power modules are essential in driving an inverter’s power-switching functions, and Hillcrest’s next-generation EV inverter features the new ZVS-enabled power modules. This enables the inverters to deliver a substantial boost in power level and power density while being designed to facilitate high-volume manufacturing in diverse industries. The company’s ZVS-enabled power modules elevate the performance and power density of the company’s EV inverter, opening up new avenues for standalone sales, noted company officials, who pointed out that with the global power module market reaching $2.7 billion in 2022 with a forecasted annual growth rate of more than 11% in the coming years, this milestone could become a valuable potential revenue stream. “Our ZVS-enabled power modules have been designed and manufactured in-house by our team and are a testament to the combined capabilities of Hillcrest and our technology development partners at Systematec GmbH,” said Hillcrest Energy Technologies chief technology officer Ari Berger in the press release. “These capabilities are pivotal to our success, especially as we engage with a growing list of potential clients in the automotive sector.”

To view the full press release, visit https://ibn.fm/u0CCx

About Hillcrest Energy Technologies Ltd.

Hillcrest Energy Technologies is a clean-technology company focused on providing advanced power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. For more information about the company, please visit www.HillcrestEnergy.tech.

NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, entered into a definitive agreement with Evofem Biosciences Inc. (OTCQB: EVFM) late last year, and Evofem is reporting its preliminary financial results for 2023, which include record net sales of Phexxi(R), its hormone-free contraceptive gel. According to the report, Phexxi is seeing a third consecutive year of net sales growth; the report also indicated that the company has reduced its total operating expenses by more than 60%. Evofem, a commercial stage women’s health innovator, and Aditxt announced the planned acquisition in December 2023, which Evofem believes is a compelling opportunity to accelerate its growth trajectory; the companies are eyeing a mid-2024 close. “Strong consumer demand for Phexxi and the expansion of coverage and reimbursement enabled us to achieve our third consecutive year of revenue growth,” said Evofem Biosciences CEO Saundra Pelletier in the press release. “We delivered more than $18 million in net sales for 2023 despite ongoing austerity measures that whittled our sales force down to just 16 and permitted no investment in growing the brand. Our growth testifies to the strength and persistence of Evofem’s current team as well as the loyal users and prescribers of Phexxi nationwide.”

To view the full press release, visit https://ibn.fm/9eQy5

About Aditxt Inc.

Aditxt is focused on discovering, developing and deploying promising health innovations. Aditxt’s diverse portfolio includes Adimune(TM) Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity and allergies; Adivir(TM) Inc., focused on identifying, developing and commercializing new ways to treat infectious diseases; and Pearsanta(TM) Inc., offering timely, convenient and high-quality personalized lab testing anytime and anywhere, backed by its CLIA-certified and CAP-accredited monitoring center. For more information, please visit www.Aditxt.com.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Haoxi Health Technology Ltd. (NASDAQ: HAO), an online marketing solution provider headquartered in Beijing, has closed on its initial public offering. According to the announcement, the offering comprised 2,400,000 Class A ordinary shares offered at $4 per share, resulting in gross proceeds of $9.6 million before deductions. The company noted that the offering closed yesterday, Jan. 30, 2024, with ordinary shares starting to trade on the NASDAQ Capital Market on Jan. 26, 2024, under the ticker symbol HAO. The company anticipates using funds from the offering for working capital and general corporate purposes, as well as to hire key employees and acquire or invest in technologies. In addition to the public offering, the company granted EF Hutton LLC, the representative of the underwriters, an option to purchase up to an additional 360,000 ordinary shares within 45 days of the closing date. The shares would be available to cover any overallotments and would be available at the public offering price, less underwriting costs. EF Hutton acted as the sole bookrunner for the Offering.

To view the full press release, visit https://ibn.fm/6XgQD

About Haoxi Health Technology Limited

Haoxi Health Technology Limited is a Beijing-headquartered online marketing solution provider in China, specializing in serving healthcare industry advertiser clients. The company’s growth is driven by the rise of news feed ads and the rapid development of the healthcare sector. The company offers one-stop online marketing solutions, especially in online short-video marketing, helping advertisers acquire and retain customers on popular platforms in China, such as Toutiao, Douyin, WeChat and Sina Weibo. Haoxi Health is dedicated to reducing costs, increasing efficiency and providing easy online marketing solutions to advertisers. For more information, please visit: http://ir.haoximedia.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Sidus Space (NASDAQ: SIDU), a multifaceted Space and Defense-as-a-Service satellite company, has announced the pricing of its underwritten public offering. The offering consists of 1,251,700 shares of SIDU Class A common stock (or prefunded warrants in lieu thereof). According to the announcement, each share of Class A common stock (or prefunded warrant) will be sold at $4.50 per share (inclusive of the prefunded warrant exercise price). The company anticipates the offering will total an estimated $5,632,650 in gross proceeds, before deducting standard underwriting discounts and offering expenses. Sidus Space intends to use funds from the offering, which is projected to close on Feb. 1, 2024, for working capital and general corporate purposes. ThinkEquity is acting as sole book-running manager for the offering.

To view the full press release, visit https://ibn.fm/PcEoJ

About Sidus Space

Sidus Space is a Space and Defense-as-a-Service satellite company focused on mission-critical hardware manufacturing; multidisciplinary engineering services; satellite design, production, launch planning and mission operations; and in-orbit support. The company is located in Cape Canaveral, Florida, where it operates from a 35,000-square-foot manufacturing, assembly, integration and testing facility focused on vertically integrated Space-as-a-Service solutions including end-to-end satellite support. Sidus Space has a mission of Bringing Space Down to Earth(TM) and a vision of enabling space flight heritage status for new technologies while delivering data and predictive analytics to domestic and global customers. Any corporation, industry or vertical can start its journey off-planet with Sidus Space’s rapidly scalable, low-cost satellite services, space-based solutions and testing alternatives. More than just a Satellite-as-a-Service provider, Sidus Space is a trusted mission partner, from concept to low earth orbit and beyond. For more information, please visit www.SidusSpace.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

DoubleDown Interactive (NASDAQ: DDI), a leading developer and publisher of digital games on mobile and web-based platforms, will release its Q4 2023 and FY 2023 financial results next month. The company plans to release the report market close on Feb. 13, 2024; the company will host a conference call and webcast at 5 p.m. ET the same day. Both the call and webcast are open to the general public. During the event, members of the DDI management team will review the financial report, provide a business update, and answer questions during a Q&A session. A replay of the call and webcast will be uploaded to the company’s investor relations website shortly after the event.

To view the webcast, visit https://ibn.fm/0JV7b

To view the full press release, visit https://ibn.fm/BtkWs

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship social casino title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. Following its acquisition of SuprNation in October 2023, the Company also operates three real-money iGaming sites in Western Europe. For more information about this company, please visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, is reporting on a recent announcement from affiliate Rail Vision Ltd. (NASDAQ: RVSN). Rail Vision announced that its next-generation artificial intelligence (“AI”)-based computer will be incorporated into its main line and switch yard systems. Foresight owns 10.2% of Rail Vision’s outstanding share capital. According to Foresight’s report, the new system features advanced real-time, deep-learning capabilities and compliance with strict railway standards, and represents significant progress compared to existing AI-based solutions. The system is designed to offer exceptional ability in obstacle detection and identification under all types of weather and visibility conditions with real-time operational capacity in both software and firmware that delivers a “new era of responsiveness and efficiency in railway safety management.” The report also noted that the system’s design focuses on scalability, meaning that it has the ability to remain at the forefront of technological advancements. A technology company focused on revolutionizing railway safety and the data-related market, Rail Vision has developed cutting-edge, artificial-intelligence-based, industry-leading technology specifically designed for railways. “Rail Vision’s next-generation AI computer system is a significant milestone in railway safety technology,” said Rail Vision CEO Shahar Hania in the press release. “This innovation embodies our unwavering commitment to advancing railway security, marrying cutting-edge AI with real-time processing to prevent accidents and save lives. Our system, technology and cloud connectivity are a transformative leap forward, marking a new chapter in intelligent railway operations.”

To view the full press release, visit https://ibn.fm/5cgMq

About Foresight Autonomous Holdings Ltd.

Foresight Autonomous Holdings is a technology company developing smart multispectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries — Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd. — Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time, precollision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information, visit the company’s website at www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Uranium Energy (NYSE American: UEC) today announced drill results from its Roughrider Project located in Northern Saskatchewan, Canada. According to the announcement, both exploration and metallurgical sample drilling have been successful at intersecting uranium mineralization. Among the highlights, the company reported discovery of new high-grade vein hosted mineralization in hole RR-889 grading 6.29% eU3O8 over 2.9 metres (“m”) ~25 m west of the East Zone deposit. “Roughrider is a world-class project with untapped potential for resource expansion, and we’re pleased to confirm this with the discovery of high-grade mineralization between the East and West Zone deposits. The drilling program will continue through the winter and focus on exploration for additional uranium that is outside the existing mineralized zones,” said Chris Hamel, VP Exploration, Canada. “Additionally, our metallurgical drilling has also confirmed the high-grade and vein-hosted nature of the Roughrider deposit with grades and thicknesses consistent with resource modelling and its structural setting. Our competitive advantage is the combination of the foundational work by Hathor and Rio Tinto with the UEC Canada Roughrider Team’s proven track record in brownfields resource expansion.”

To view the full press release, visit https://ibn.fm/ivKGv

About Uranium Energy Corp.

Uranium Energy is the fastest growing supplier of the fuel for the green energy transition to a low carbon future. UEC is the largest, diversified North American focused uranium company, advancing the next generation of low-cost, environmentally friendly In-Situ Recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms located in South Texas and Wyoming. These platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, the company has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, has named a new chief financial officer; the company announced that Stacy McLaughlin will be joining the company. As CFO, McLaughlin will overseeing all financial aspects of the company including accounting, tax, financial planning and analysis, treasury, M&A activities and capital markets. Previously the chief financial officer at Material Technologies Corp., McLaughlin has more than two decades of experience in the finance and accounting spaces. Before she served at Material Technologies, she worked at Willdan Group Inc., joining the company as compliance manager and eventually becoming vice president and CFO. While at Willdan, she managed accounting and finance functions, SEC reporting, investor relations and treasury, as well as a follow-on equity offering. Other roles she has taken on include senior associate at Windes & McClaughry Accountancy Corporation and senior audit associate KPMG LLP. “Stacy’s impressive financial and operational experience, especially her deep knowledge of public finance and accounting, capital markets, in addition to managing $400 million in revenue in a previous role, will be a tremendous asset to our executive team at Splash,” said Splash Beverage CEO Robert Nistico in the press release. “Someone of Stacy’s caliber joining the team is an important validation of our vision, ‘growth through acquisition and public compliance.’ Stacy is stepping into a critical role, and her financial acumen is exactly what we need, at exactly the right time. We’re thrilled to have her on the executive team and look forward to her contributions to our continued success at Splash.”

To view the full press release, visit https://ibn.fm/ICpAz

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and nonalcoholic beverage brands including Copa di Vino wines by the glass, SALT flavored tequilas, Pulpoloco sangrias, and TapouT performance hydration and recovery drinks. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, please visit www.SplashBeverageGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

LQWD Technologies (TSX.V: LQWD) (OTC: LQWDF), a leading infrastructure and liquidity provider for the Bitcoin Lightning Network as well as a holder of Bitcoin as an operational asset, has announced the milestone of surpassing over 325,000 in transaction routing volume across the company’s global node network. “We are beginning to see a network effect taking place with 1,200% growth in transactions over the LN in the past two years as well as increasing interest and funding from venture capital companies,” said LQWD CEO Shone Anstey. “Our team is very excited and can foresee the opportunities for LQWD as the only publicly traded Bitcoin Lightning Network pure play within the rapidly growing eco-system. Furthermore, LQWD is firmly established as a LN-focused company with a revenue generating model in place to capture continued growth of the network and the associated transaction fee revenue.”

To view the full press release, visit https://ibn.fm/EmKGm

About LQWD Technologies Corp.

LQWD is a Bitcoin Lightning Network Liquidity Provider focused on developing payment infrastructure and solutions accelerating the global mega trend of Bitcoin adoption through the Lightning Network. LQWD also owns Bitcoin that is used as an operating asset establishing nodes and payment channels on the Lightning Network.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

ARX has issued an important update regarding new regulations implemented by the Securities and Exchange Commission (“SEC”) effective Jan. 24, 2024. The regulations are concerning Special Purpose Acquisition Companies (“SPACs”) and de-SPAC transactions, with the rules signifying a major shift in the regulatory framework, enhancing transparency and investor protection in SPAC activities. “The implementation of the SEC’s new regulations on SPACs coincides with a downturn in market activity, heralding a shift towards increased oversight. This change aims to bolster market stability through enhanced transparency and investor protection. Consequently, SPACs are likely to adopt more cautious financial projections, and the market may witness a trend towards fewer but more substantial and financially solid deals,” the report reads. “For investors, this environment suggests a need for greater discernment in SPAC investments. It’s expected that experienced SPAC sponsors, adept at navigating these new regulatory landscapes, will continue to find success. This shift could lead to a more mature and reliable market, emphasizing quality over quantity in SPAC transactions. Looking ahead, the SEC’s new rules mark a pivotal moment for SPACs, potentially reshaping the landscape of public offerings.”

To view the full report, visit https://ibn.fm/8r0uX

About ARX Capital Markets

ARX is rethinking capital markets and providing data-backed solutions for pre- and post-IPO companies. ARX enables growth, insights and threat mitigation in a world of fragmented and uncorrelated investor data. For more information, visit https://arxadvisory.com.

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Sigyn Therapeutics (OTCQB: SIGY), a development-stage medical technology company, has announced a 1-for-40 reverse split of its common stock. The reverse split will go into effect tomorrow, Jan. 31, 2024. According to the company, its common stock will trade on a post-split basis at the beginning of the trading day on Jan. 31, under its existing trading symbol: SIGY. The announcement included pertinent stockholder information regarding the upcoming split. “The reverse stock split is intended to increase the market price per share of the company’s common stock to gain compliance with the minimum bid listing requirement of the NASDAQ Capital Market in connection with the company’s pending application for listing,” the company stated in the press release. “Proportionate adjustments will be made to the conversion and exercise prices of the company’s warrants, restricted stock unit awards, stock options and to the number of shares issued and issuable under the company’s equity incentive plans.”

To view the full press release, visit https://ibn.fm/HbXT3

About Sigyn Therapeutics Inc.

Sigyn Therapeutics is a development-stage, medical-technology company headquartered in San Diego, California. The company’s therapeutic candidates are designed to overcome clearly defined limitations in healthcare. These include the ImmunePrepplatform, ChemoPrep, ChemoPure and Sigyn Therapy. ImmunePrep is a development-stage commercialization platform to enhance and extend the performance of immunotherapeutic antibodies, which account for 9 of the top 15 best-selling cancer therapy drugs. ChemoPrep is designed to optimize the delivery of chemotherapy, the most commonly administered drug to treat cancer, while ChemoPureextracts  off-target chemotherapy from the bloodstream to reduce treatment toxicity. Sigyn Therapy is a novel blood-purification technology being advanced to treat pathogen-associated inflammatory disorders. To date, in vitro studies have demonstrated the ability of Sigyn Therapyto reduce the circulating prevalence of 12 different pathogen and inflammatory-disease targets from human blood plasma. Based on these outcomes, candidate treatment indications include community-acquired pneumonia, endotoxemia, drug-resistant viral and bacterial infections, and sepsis, the leading cause of hospital deaths in the United States. First-in-human feasibility studies of Sigyn Therapy plan to enroll end-stage renal disease (“ESRD”) patients with endotoxemia and concurrent inflammation, which are highly prevalent and associated with increased mortality in the ESRD population. For more information, visit the company’s website at www.SigynTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to SIGY are available in the company’s newsroom at https://ibn.fm/SIGY  

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has submitted its much-anticipated Investigational New Drug (“IND”) application with the U.S. Food and Drug Administration (“FDA”). The application covers HYPER-H23-1, the company’s upcoming planned U.S. phase 1b hypertension clinical trial of DehydraTECH-CBD. According to the announcement, the company had a successful pre-IND meeting with FDA officials. Following the guidance provided in that meeting regarding the development and filing of the IND, the company submitted the application on Jan. 29, 2024. The company will now wait 30 calendar days before initiating any clinical trials, in compliance with FDA guidelines. During that 30-day period, the FDA may review the IND for safety concerns. The primary focus of the trial will be to evaluate safety and tolerability in hypertensive patients with secondary goals including to study the efficacy of reducing blood pressure together with detailed pharmacokinetic testing. “Lexaria looks forward to commencing clinical trial HYPER-H23-1 as soon as possible following IND effectiveness, subject to certain conditions, including funding,” the company stated in the press release. “The IND review process when successfully concluded will be an important milestone achievement for Lexaria demonstrating that its DehydraTECH technology has met high-level formal regulatory scrutiny towards prospective future pharmaceutical commercial registration.”

To view the full press release, visit https://ibn.fm/zbCfg

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery formulation and processing platform technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream through oral delivery. Since 2016, Lexaria has developed and investigated DehydraTECH with a variety of beneficial molecules in oral and topical formats. DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption and has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier, which Lexaria believes to be of particular importance for centrally active compounds. Lexaria operates a licensed, in-house research laboratory and holds a robust intellectual property portfolio with 38 patents granted and many patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Aditxt (NASDAQ: ADTX), a company dedicated to discovering, developing and deploying promising health innovations, has announced its acquisition of a portfolio of electroencephalography “EEG” brain monitoring technologies and devices formerly owned by Brain Scientific, Inc. The products targeting the neurology monitoring market will be essential in shaping its dynamic landscape for neurological care. “This transaction represents yet another example of how Aditxt accelerates the growth of its subsidiaries through innovation,” said Amro Albanna, co-founder, chairman and CEO of Aditxt. “Integrating these pioneering brain monitoring technologies and devices into Pearsanta will enable it to address critical needs and expand its commercial opportunities globally.”

To view the full press release, visit https://ibn.fm/RFXSz

About Aditxt Inc.

Aditxt is focused on discovering, developing and deploying promising health innovations. Aditxt’s diverse portfolio includes Adimune(TM), developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity and allergies; Adivir(TM), focused on identifying, developing and commercializing new ways to treat infectious diseases; and Pearsanta(TM), offering timely, convenient and high-quality personalized lab testing anytime and anywhere, backed by its CLIA-certified and CAP-accredited monitoring center. For more information, visit the company’s website at www.Aditxt.com.

NOTE TO INVESTORS: The latest news and updates relating to ADTX are available in the company’s newsroom at https://ibn.fm/ADTX

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN

Hillcrest Energy Technologies (CSE: HEAT) (OTCQB: HLRTF) (FSE: 7HI), an innovative clean-technology company redefining power-conversion technologies, is reporting the status of key activities for this year. According to the announcement, the company is building on accomplishments from last year as it continues to engage with potential customers and partners and work toward the commercialization of its technology across various applications. In Q1 2024, the company has already secured demonstrations and advanced testing opportunities with four automotive original equipment manufacturer (“OEMs”) and a global tier-one supplier and will complete an in-water demonstration with Hercules Electric Mobility’s e-boat. In addition, the company is conducting  ongoing discussions with a variety of entities, including a prominent European automotive OEM, a global tier-one supplier and Hercules Electric Mobility about potential joint-development opportunities. The company noted that it is using its next-generation EV inverter — a cutting-edge inverter that leverages 350-kilowatt silicon carbide (“SiC”) technology and is designed for applications up to 1,000 volts — for demonstration and advanced testing programs. “After achieving significant breakthroughs in technology launches and securing multiple commercial engagements in 2023, our primary focuses in 2024 are to further amplify our customer engagements and secure commercial commitments,” said Hillcrest Energy Technologies CEO Don Currie in the press release.

To view the full press release, visit https://ibn.fm/iiteu

About Hillcrest Energy Technologies Ltd.

Hillcrest Energy Technologies is a clean-technology company focused on providing advanced power conversion technologies and digital control systems for next-generation powertrains and grid-connected renewable energy systems. From concept to commercialization, Hillcrest is investing in the development of energy solutions that will power a more sustainable and electrified future. For more information about the company, please visit www.HillcrestEnergy.tech.

NOTE TO INVESTORS: The latest news and updates relating to HLRTF are available in the company’s newsroom at https://ibn.fm/HLRTF

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
[email protected]

InvestorWire is powered by IBN